Papanicolaou smears and cervical inflammatory cytokine responses

<p>Abstract</p> <p>In a case-control study among 2064 South African women to investigate the risk of clinically invasive cancer of the cervix, we found a marked reduction in the risk of cervical cancer among women who gave a history of ever having undergone even a single Pap smear,...

Full description

Bibliographic Details
Main Authors: Shapiro Samual, Williamson Anna-Lise, Morroni Chelsea, Passmore Jo-Ann S, Hoffman Margaret
Format: Article
Language:English
Published: BMC 2007-04-01
Series:Journal of Inflammation
Online Access:http://www.journal-inflammation.com/content/4/1/8
_version_ 1818524512278282240
author Shapiro Samual
Williamson Anna-Lise
Morroni Chelsea
Passmore Jo-Ann S
Hoffman Margaret
author_facet Shapiro Samual
Williamson Anna-Lise
Morroni Chelsea
Passmore Jo-Ann S
Hoffman Margaret
author_sort Shapiro Samual
collection DOAJ
description <p>Abstract</p> <p>In a case-control study among 2064 South African women to investigate the risk of clinically invasive cancer of the cervix, we found a marked reduction in the risk of cervical cancer among women who gave a history of ever having undergone even a single Pap smear, and a statistically significant decline in the HPV positivity rate correlated with the lifetime number of Pap smears received. HPV infections and their associated low-grade lesions commonly regress, indicating that most often there is an effective host immune response against HPV infection. We hypothesized that act of performing a Pap smear is associated with inflammatory responses at the site of trauma, the cervix, and that this inflammatory signalling may be an immunological factor initiating these productive anti-HPV responses. In the present study, a randomized controlled trial, we enrolled 80 healthy young women to investigate the impact of performing a Pap smear on cervical inflammation. Forty one women, in the intervention group, received a Pap smear at enrollment and cervicovaginal lavages (CVLs) were collected at baseline and 2 weeks later. Thirty nine women received no intervention at enrollment (control group) but CVLs were collected at enrolment and 2 weeks later. We assessed various markers of inflammation including IL-12 p70, TNF-α, IL-8, IL-6, IL-10, and IL-1β in CVL specimens. While CVL levels of IL-8, IL-1β and IL-6 remained unchanged following a Pap smear, markers of cell mediated immunity (IL-12 p70 and TNF-α) and T cell regulation (IL-10) were significantly elevated.</p>
first_indexed 2024-12-11T05:58:02Z
format Article
id doaj.art-2bdcaf841d094c45abfd2deebf599e81
institution Directory Open Access Journal
issn 1476-9255
language English
last_indexed 2024-12-11T05:58:02Z
publishDate 2007-04-01
publisher BMC
record_format Article
series Journal of Inflammation
spelling doaj.art-2bdcaf841d094c45abfd2deebf599e812022-12-22T01:18:35ZengBMCJournal of Inflammation1476-92552007-04-0141810.1186/1476-9255-4-8Papanicolaou smears and cervical inflammatory cytokine responsesShapiro SamualWilliamson Anna-LiseMorroni ChelseaPassmore Jo-Ann SHoffman Margaret<p>Abstract</p> <p>In a case-control study among 2064 South African women to investigate the risk of clinically invasive cancer of the cervix, we found a marked reduction in the risk of cervical cancer among women who gave a history of ever having undergone even a single Pap smear, and a statistically significant decline in the HPV positivity rate correlated with the lifetime number of Pap smears received. HPV infections and their associated low-grade lesions commonly regress, indicating that most often there is an effective host immune response against HPV infection. We hypothesized that act of performing a Pap smear is associated with inflammatory responses at the site of trauma, the cervix, and that this inflammatory signalling may be an immunological factor initiating these productive anti-HPV responses. In the present study, a randomized controlled trial, we enrolled 80 healthy young women to investigate the impact of performing a Pap smear on cervical inflammation. Forty one women, in the intervention group, received a Pap smear at enrollment and cervicovaginal lavages (CVLs) were collected at baseline and 2 weeks later. Thirty nine women received no intervention at enrollment (control group) but CVLs were collected at enrolment and 2 weeks later. We assessed various markers of inflammation including IL-12 p70, TNF-α, IL-8, IL-6, IL-10, and IL-1β in CVL specimens. While CVL levels of IL-8, IL-1β and IL-6 remained unchanged following a Pap smear, markers of cell mediated immunity (IL-12 p70 and TNF-α) and T cell regulation (IL-10) were significantly elevated.</p>http://www.journal-inflammation.com/content/4/1/8
spellingShingle Shapiro Samual
Williamson Anna-Lise
Morroni Chelsea
Passmore Jo-Ann S
Hoffman Margaret
Papanicolaou smears and cervical inflammatory cytokine responses
Journal of Inflammation
title Papanicolaou smears and cervical inflammatory cytokine responses
title_full Papanicolaou smears and cervical inflammatory cytokine responses
title_fullStr Papanicolaou smears and cervical inflammatory cytokine responses
title_full_unstemmed Papanicolaou smears and cervical inflammatory cytokine responses
title_short Papanicolaou smears and cervical inflammatory cytokine responses
title_sort papanicolaou smears and cervical inflammatory cytokine responses
url http://www.journal-inflammation.com/content/4/1/8
work_keys_str_mv AT shapirosamual papanicolaousmearsandcervicalinflammatorycytokineresponses
AT williamsonannalise papanicolaousmearsandcervicalinflammatorycytokineresponses
AT morronichelsea papanicolaousmearsandcervicalinflammatorycytokineresponses
AT passmorejoanns papanicolaousmearsandcervicalinflammatorycytokineresponses
AT hoffmanmargaret papanicolaousmearsandcervicalinflammatorycytokineresponses